We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Releases Guidance on Cancer Trial Endpoints
FDA Releases Guidance on Cancer Trial Endpoints
April 8, 2005
The FDA has released the first in a series of guidance documents that provide recommendations on clinical trial endpoints for the approval of cancer drugs and biologics.